STOL Simulation Requirements for Development of Integrated Flight/propulsion Control Systems

The role and use of simulation as a design tool in developing integrated systems where design criteria is largely unavailable is well known. This paper addresses additional simulation needs for the development of Integrated Flight/Propulsion Control Systems (IFPCS) which will improve the probability of properly interpreting simulation results. These needs are based on recent experience with power approach flying qualities evaluations of an advanced fighter configuration which incorporated Short Takeoff and Landing (STOL) technologies and earlier experiences with power approach flying qualities evaluations on the AFTI/F-16 program. The use of motion base platforms with axial and normal degrees of freedom will help in evaluating pilot coupling and workload in the presence of high frequency low amplitude axial accelerations produced by high bandwidth airspeed controllers in a gusty environment

Optical projector system Patent

Optical projector system for establishing optimum arrangement of instrument displays in aircraft, spacecraft, other vehicles, and industrial instrument console

Bimodal Feedback for In-car Mid-air Gesture Interaction

This demonstration showcases novel multimodal feedback designs for in-car mid-air gesture interaction. It explores the potential of multimodal feedback types for mid-air gestures in cars and how these can reduce eyes-off-the-road time thus make driving safer. We will show four different bimodal feedback combinations to provide effective information about interaction with systems in a car. These feedback techniques are visual-auditory, auditory-ambient (peripheral vision), ambient-tactile, and tactile-auditory. Users can interact with the system after a short introduction, creating an exciting opportunity to deploy these displays in cars in the future

Is a Picture Worth a Thousand Words? An Evaluation of Information Awareness Displays

Little is known about what makes a peripheral or ambient display effective at presenting awareness information or simply, if one is better than another. Furthermore, techniques for evaluating these types of displays are just beginning to be developed. We conducted an evaluation of the InfoCanvas, a peripheral display that conveys awareness information graphically as a form of information art. We assessed people's comprehension of information presented by the InfoCanvas compared to two other electronic information displays, a Web portal style and a text-based display, when each display was viewed for a short period of time. We found that participants noted and recalled significantly more information when presented by the InfoCanvas than by either of the other displays despite having to learn the additional graphical representations employed by the InfoCanvas

I Am The Passenger: How Visual Motion Cues Can Influence Sickness For In-Car VR

This paper explores the use of VR Head Mounted Displays (HMDs) in-car and in-motion for the first time. Immersive HMDs are becoming everyday consumer items and, as they offer new possibilities for entertainment and productivity, people will want to use them during travel in, for example, autonomous cars. However, their use is confounded by motion sickness caused in-part by the restricted visual perception of motion conflicting with physically perceived vehicle motion (accelerations/rotations detected by the vestibular system). Whilst VR HMDs restrict visual perception of motion, they could also render it virtually, potentially alleviating sensory conflict. To study this problem, we conducted the first on-road and in motion study to systematically investigate the effects of various visual presentations of the real-world motion of a car on the sickness and immersion of VR HMD wearing passengers. We established new baselines for VR in-car motion sickness, and found that there is no one best presentation with respect to balancing sickness and immersion. Instead, user preferences suggest different solutions are required for differently susceptible users to provide usable VR in-car. This work provides formative insights for VR designers and an entry point for further research into enabling use of VR HMDs, and the rich experiences they offer, when travelling

Smart driving assistance systems : designing and evaluating ecological and conventional displays

In-vehicle information systems have been shown to increase driver workload and cause distraction; both are causal factors for accidents. This simulator study evaluates the impact that two designs for a smart driving aid and scenario complexity has on workload, distraction and driving performance. Results showed that real-time delivery of smart driving information did not increase driver workload or adversely affect driver distraction, while having the effect of decreasing mean driving speed in both the simple and complex driving scenarios. Important differences were also highlighted between conventional and ecologically designed smart driving interfaces with respect to subjective workload and peripheral detection

Aerospace Medicine and Biology: A continuing bibliography with indexes (supplement 291)

This bibliography lists 131 reports, articles and other documents introduced into the NASA scientific and technical information system in November 1986

Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH

Aim Traditionally, risk stratification in heart failure (HF) emphasizes assessment of high risk. We aimed to determine if biomarkers could identify patients with HF at low risk for death or HF rehospitalization. Methods and results This analysis was a substudy of The Coordinating Study Evaluating Outcomes of Advising and Counselling in Heart Failure (COACH) trial. Enrolment of HF patients occurred before discharge. We defined low risk as the absence of death and/or HF rehospitalizations at 180 days. We tested a diverse group of 29 biomarkers on top of a clinical risk model, with and without N-terminal pro-B-type natriuretic peptide (NT-proBNP), and defined the low risk biomarker cut-off at the 10th percentile associated with high positive predictive value. The best performing biomarkers together with NT-proBNP and cardiac troponin I (cTnI) were re-evaluated in a validation cohort of 285 HF patients. Of 592 eligible COACH patients, the mean (± SD) age was 71 (± 11) years and median (IQR) NT-proBNP was 2521 (1301-5634) pg/mL. Logistic regression analysis showed that only galectin-3, fully adjusted, was significantly associated with the absence of events at 180 days (OR 8.1, 95% confidence interval 1.06-50.0, P = 0.039). Galectin-3, showed incremental value when added to the clinical risk model without NT-proBNP (increase in area under the curve from 0.712 to 0.745, P = 0.04). However, no biomarker showed significant improvement by net reclassification improvement on top of the clinical risk model, with or without NT-proBNP. We confirmed our results regarding galectin-3, NT-proBNP, and cTnI in the independent validation cohort. Conclusion We describe the value of various biomarkers to define low risk, and demonstrate that galectin-3 identifies HF patients at (very) low risk for 30-day and 180-day mortality and HF rehospitalizations after an episode of acute HF. Such patients might be safely discharged